Pharmaceutical Executive, November 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2020 issue in an interactive PDF format.
Articles in this issue
Synthetic Biology and the Environment
Measuring Pharma’s Wider Mandate
Patients as the North Star
Going Public During Lockdown: IPO Insights from Five Biotechnology CFOs
A Rare-Disease Must? Building Long-Term Relationships
Making Remote Work a Success Beyond COVID
CRISPR for Diversity, and Humanity’s, Sake
Expediting the Cancer Treatment Path
Vaccine Authorization, Distribution Raise Multiple Challenges
Pharmaceutical Executive, November 2020 Issue (PDF)
EU Leaders in High-Stakes Gamble on COVID Responses
Access & Gene Therapies: Uncertainties Impact Commercial Uptake
Case Study: A Drug Launch into COVID Headwinds
A Record Year, But Will Recent Valuation Fatigue Continue?
Advancing the Science for Minds: Dr. Husseini Manji, J&J
Recent Videos
Related Content
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Podcast
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
